Abbott Laboratories
Close on Nov 2, 2026Market cap $190.62BP/E 35.4Yield 2.18%
Abbott Laboratories Core Laboratory — U.S. COVID-19 Testing Sales by Year
Core Laboratory — U.S. COVID-19 Testing Sales ($M) ($M)
Abbott Laboratories Core Laboratory — U.S. COVID-19 Testing Sales: $4M in FY2024, down 42.9% from a year earlier. No newer figure appears in the documents we track.
Where the FY2024 figure comes from
“|| Sales 12M24 | COVID Tests Sales 12M24 || Core Laboratory | 1,332 | 3,903 | 5,235 | 4 | 6 | 10”
Source: SEC Filing (0001628280-25-002092) ↗
Reported in Form 8-K Quarterly Earnings Releases (Item 2.02 Revenue Tables) & Form 10-K/10-Q MD&A.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Core Laboratory — U.S. COVID-19 Testing Sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2024 | Dec 31, 2024 | 4 | -42.9% | SEC Filing (0001628280-25-002092) ↗ |
| FY2023 | Dec 31, 2023 | 7 | -56.2% | SEC Filing (0001628280-25-002092) ↗ |
| FY2022 | Dec 31, 2022 | 16 | -56.8% | SEC Filing (0001628280-24-002009) ↗ |
| FY2021 | Dec 31, 2021 | 37 | – | SEC Filing (0001628280-23-001516) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Core Laboratory — U.S. COVID-19 Testing Sales ($M), annual FY2021–FY2024 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/dx-cl-covid-us
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.